CDW Reports First Quarter 2022 Earnings
CDW Corporation (Nasdaq: CDW) reported impressive first quarter 2022 results, with net sales reaching $5,949 million, a 23% increase from $4,838 million in 2021. The gross profit rose 38.8%, totaling $1,104 million, while net income increased 7.6% to $250 million. Non-GAAP net income per diluted share grew 26.6% to $2.20. The company plans to continue leveraging cash flow for debt reduction. CDW anticipates exceeding its 2022 growth outlook by up to 300 basis points compared to the US IT market growth.
- Net sales grew 23% year-over-year to $5,949 million.
- Gross profit increased 38.8% to $1,104 million.
- Non-GAAP net income per diluted share rose 26.6% to $2.20.
- Operating income improved by 19.6% to $387 million.
- Selling and administrative expenses surged 52% to $717 million.
- Net interest expense increased to $56 million from $36 million due to the acquisition of Sirius.
(Dollars in millions, except per share amounts) |
Three Months Ended |
||||
|
2022 |
|
2021 |
% Chg. |
|
|
$ |
5,949.1 |
$ |
4,837.5 |
23.0 |
Average Daily Sales1 |
|
94.4 |
|
76.8 |
23.0 |
Gross Profit |
|
1,104.1 |
|
795.2 |
38.8 |
Operating Income |
|
386.9 |
|
323.4 |
19.6 |
Net Income |
|
250.2 |
|
232.6 |
7.6 |
Non-GAAP Operating Income2 |
|
462.1 |
|
367.7 |
25.7 |
Net Income per Diluted Share |
$ |
1.83 |
$ |
1.63 |
12.6 |
Non-GAAP Net Income per Diluted Share2 |
$ |
2.20 |
$ |
1.74 |
26.6 |
1 There were 63 selling days for both the three months ended |
|||||
2 Non-GAAP measures used in this release that are not based on accounting principles generally accepted in |
“We delivered record Net sales and excellent profitability, reinforcing confidence in our strategy for growth. Our first quarter results once again highlight the strength of our business model and the combined power of our diverse customer end markets and broad product and solutions portfolio," said
“Strong operating results, inclusive of our 2021 acquisition of Sirius delivered outstanding earnings growth with a 13 and 27 percent increase in GAAP and Non-GAAP earnings per diluted share,” said
“We expect to exceed our initial 2022 outlook to outpace US IT market growth by 200 to 300 basis points on a constant currency basis. We will continue to execute our strategy, invest in the business, and be laser-focused on meeting the needs of our more than 250,000 customers around the globe and remain the partner of choice for more than 1,000 leading and emerging technology brands as the market continues to evolve," concluded Leahy.
First Quarter of 2022 Highlights:
Total Net sales in the first quarter of 2022 were
-
Total Corporate segment Net sales of
, 45.5 percent higher than 2021.$2,628 million
-
Total Small Business segment Net sales of
, 21.1 percent higher than 2021.$524 million
-
Total Public segment Net sales of
, 5.8 percent higher than 2021. Public results were driven by an increase in Net sales to Healthcare and Government customers of 26.8 percent and 5.4 percent, respectively. Net sales to Education customers decreased 4.3 percent.$2,033 million
-
Net sales for CDW's
UK and Canadian operations, combined as “Other” for financial reporting purposes, were , 12.8 percent higher than 2021.$765 million
Gross profit in the first quarter of 2022 was
Total selling and administrative expenses were
Operating income was
Net interest expense was
The effective tax rate was 24.3 percent in the first quarter of 2022, compared to 19.5 percent in the first quarter of 2021, which resulted in tax expense of
Net income was
Weighted average diluted shares outstanding were 137 million for the first quarter of 2022, compared to 143 million for 2021. Net income per diluted share for the first quarter of 2022 was
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the federal securities laws. All statements other than statements of historical fact are forward-looking statements. These statements relate to analyses and other information, which are based on forecasts of future results or events and estimates of amounts not yet determinable. These statements also relate to our future prospects, developments and business strategies. We claim the protection of The Private Securities Litigation Reform Act of 1995 for all forward-looking statements in this release.
These forward-looking statements are identified by the use of terms and phrases such as "anticipate," "assume," "believe," "estimate," "expect," "goal," "intend," "plan," "potential," "predict," "project," "target" and similar terms and phrases or future or conditional verbs such as "could," "may," "should," "will," and "would." However, these words are not the exclusive means of identifying such statements. Although we believe that our plans, intentions and other expectations reflected in or suggested by such forward-looking statements are reasonable, we cannot assure you that we will achieve those plans, intentions or expectations. All forward-looking statements are subject to risks and uncertainties that may cause actual results or events to differ materially from those that we expected.
Important factors that could cause actual results or events to differ materially from our expectations, or cautionary statements, are disclosed under the section entitled "Risk Factors" included in our Annual Report on Form 10-K for the year ended
We caution you that the important factors referenced above may not reflect all of the factors that could cause actual results or events to differ from our expectations. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. The forward-looking statements included in this release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.
Non-GAAP Financial Information
Non-GAAP operating income excludes, among other things, charges related to the amortization of acquisition-related intangible assets, equity-based compensation and related payroll taxes, and acquisition and integration expenses. Non-GAAP operating income margin is defined as Non-GAAP operating income as a percentage of Net sales. Non-GAAP income before income taxes and Non-GAAP net income exclude, among other things, charges related to acquisition-related intangible asset amortization, equity-based compensation, acquisition and integration expenses, and the associated tax effects of each. Net sales growth on a constant currency basis is defined as Net sales growth excluding the impact of foreign currency translation on Net sales compared to the prior period.
Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP income before income taxes, Non-GAAP net income, Non-GAAP net income per diluted share and Net sales growth on a constant currency basis are considered non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial condition that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with US GAAP.
CDW believes these measures provide analysts, investors and management with helpful information regarding the underlying operating performance of CDW's business, as they remove the impact of items that management believes are not reflective of underlying operating performance. CDW uses these measures to evaluate period-over-period performance as management believes they provide a more comparable measure of the underlying business. Certain non-GAAP financial measures are also used to determine certain components of performance-based compensation.
CDW's annual targets are provided on a non-GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as currency impacts or interest rates, or reliably predicted because they are not part of CDW's routine activities, such as refinancing activities or acquisition and integration expenses.
The financial statement tables that accompany this press release include a reconciliation of non-GAAP financial measures to the applicable most comparable US GAAP financial measures. Non-GAAP measures used by CDW may differ from similar measures used by other companies, even when similar terms are used to identify such measures.
About CDW
Webcast
CDWPR-FI
CDW CORPORATION AND SUBSIDIARIES |
|||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||
(dollars and shares in millions, except per-share amounts) |
|||||||||||
(unaudited) |
|||||||||||
|
|
Three Months Ended |
|||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
% Change(i) |
|
|
|
|
|
|
|
|
|||||
Net sales |
|
$ |
5,949.1 |
|
|
$ |
4,837.5 |
|
|
23.0 |
% |
Cost of sales |
|
|
4,845.0 |
|
|
|
4,042.3 |
|
|
19.9 |
|
|
|
|
|
|
|
|
|||||
Gross profit |
|
|
1,104.1 |
|
|
|
795.2 |
|
|
38.8 |
|
|
|
|
|
|
|
|
|||||
Selling and administrative expenses |
|
|
717.2 |
|
|
|
471.8 |
|
|
52.0 |
|
Operating income |
|
|
386.9 |
|
|
|
323.4 |
|
|
19.6 |
|
|
|
|
|
|
|
|
|||||
Interest expense, net |
|
|
(56.0 |
) |
|
|
(35.6 |
) |
|
57.5 |
|
Other (expense) income, net |
|
|
(0.5 |
) |
|
|
1.1 |
|
|
n.m.* |
|
|
|
|
|
|
|
|
|||||
Income before income taxes |
|
|
330.4 |
|
|
|
288.9 |
|
|
14.4 |
|
|
|
|
|
|
|
|
|||||
Income tax expense |
|
|
(80.2 |
) |
|
|
(56.3 |
) |
|
42.6 |
|
|
|
|
|
|
|
|
|||||
Net income |
|
$ |
250.2 |
|
|
$ |
232.6 |
|
|
7.6 |
% |
|
|
|
|
|
|
|
|||||
Net income per common share: |
|
|
|
|
|
|
|||||
Basic |
|
$ |
1.85 |
|
|
$ |
1.65 |
|
|
12.5 |
% |
Diluted |
|
$ |
1.83 |
|
|
$ |
1.63 |
|
|
12.6 |
% |
|
|
|
|
|
|
|
|||||
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|||||
Basic |
|
|
134.9 |
|
|
|
141.1 |
|
|
|
|
Diluted |
|
|
136.7 |
|
|
|
143.1 |
|
|
|
* |
not meaningful |
|
|
(i) |
There were 63 selling days for both the three months ended |
CDW CORPORATION AND SUBSIDIARIES
NON-GAAP FINANCIAL MEASURE RECONCILIATIONS
CDW has included reconciliations of Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP income before income taxes, Non-GAAP net income, Non-GAAP net income per diluted share and Net sales growth on a constant currency basis for the three months ended
CDW CORPORATION AND SUBSIDIARIES |
|||||||||||
NON-GAAP OPERATING INCOME AND NON-GAAP OPERATING INCOME MARGIN |
|||||||||||
(dollars in millions) |
|||||||||||
(unaudited) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
2022 |
|
% of Net sales |
|
|
2021 |
|
% of Net sales |
||
|
|
|
|
|
|
|
|
||||
Operating income, as reported |
$ |
386.9 |
|
6.5 |
% |
|
$ |
323.4 |
|
6.7 |
% |
Amortization of intangibles(i) |
|
40.9 |
|
|
|
|
21.6 |
|
|
||
Equity-based compensation |
|
21.1 |
|
|
|
|
15.8 |
|
|
||
Acquisition and integration expenses |
|
11.7 |
|
|
|
|
3.6 |
|
|
||
Other adjustments |
|
1.5 |
|
|
|
|
3.3 |
|
|
||
Non-GAAP operating income |
$ |
462.1 |
|
7.8 |
% |
|
$ |
367.7 |
|
7.6 |
% |
(i) |
Includes amortization expense for acquisition-related intangible assets, primarily customer relationships, customer contracts and trade names. |
CDW CORPORATION AND SUBSIDIARIES |
|||||||||||||||||||||||||||||
NON-GAAP INCOME BEFORE INCOME TAXES, NON-GAAP NET INCOME |
|||||||||||||||||||||||||||||
AND NON-GAAP NET INCOME PER DILUTED SHARE |
|||||||||||||||||||||||||||||
(dollars and shares in millions, except per-share amounts) |
|||||||||||||||||||||||||||||
(unaudited) |
|||||||||||||||||||||||||||||
|
Three Months Ended |
|
|
||||||||||||||||||||||||||
|
2022 |
|
2021 |
|
|
||||||||||||||||||||||||
|
Income before Income Taxes |
|
Income Tax Expense(i) |
|
Net Income |
|
Effective Tax Rate |
|
Income before Income Taxes |
|
Income Tax Expense(i) |
|
Net Income |
|
Effective Tax Rate |
|
Net Income % Change |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
US GAAP, as reported |
$ |
330.4 |
|
$ |
(80.2 |
) |
|
$ |
250.2 |
|
24.3 |
% |
|
$ |
288.9 |
|
$ |
(56.3 |
) |
|
$ |
232.6 |
|
|
19.5 |
% |
|
7.6 |
% |
Amortization of intangibles(ii) |
|
40.9 |
|
|
(10.6 |
) |
|
|
30.3 |
|
|
|
|
21.6 |
|
|
(5.4 |
) |
|
|
16.2 |
|
|
|
|
|
|||
Equity-based compensation |
|
21.1 |
|
|
(9.8 |
) |
|
|
11.3 |
|
|
|
|
15.8 |
|
|
(20.8 |
) |
|
|
(5.0 |
) |
|
|
|
|
|||
Acquisition and integration expenses |
|
11.7 |
|
|
(3.0 |
) |
|
|
8.7 |
|
|
|
|
3.6 |
|
|
(0.9 |
) |
|
|
2.7 |
|
|
|
|
|
|||
Other adjustments |
|
1.4 |
|
|
(0.4 |
) |
|
|
1.0 |
|
|
|
|
3.7 |
|
|
(0.8 |
) |
|
|
2.9 |
|
|
|
|
|
|||
Non-GAAP |
$ |
405.5 |
|
$ |
(104.0 |
) |
|
$ |
301.5 |
|
25.7 |
% |
|
$ |
333.6 |
|
$ |
(84.2 |
) |
|
$ |
249.4 |
|
|
25.2 |
% |
|
20.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
US GAAP net income per diluted share |
|
|
|
|
$ |
1.83 |
|
|
|
|
|
|
|
$ |
1.63 |
|
|
|
|
|
|||||||||
Non-GAAP net income per diluted share |
|
|
|
|
$ |
2.20 |
|
|
|
|
|
|
|
$ |
1.74 |
|
|
|
|
|
|||||||||
Shares used in computing US GAAP and Non-GAAP net income per diluted share |
|
|
|
|
|
136.7 |
|
|
|
|
|
|
|
|
143.1 |
|
|
|
|
|
(i) |
Income tax on non-GAAP adjustments includes excess tax benefits associated with equity-based compensation. |
(ii) |
Includes amortization expense for acquisition-related intangible assets, primarily customer relationships, customer contracts and trade names. |
CDW CORPORATION AND SUBSIDIARIES |
|||||||||||
NET SALES GROWTH ON A CONSTANT CURRENCY BASIS |
|||||||||||
(dollars in millions) |
|||||||||||
(unaudited) |
|||||||||||
|
|
Three Months Ended |
|||||||||
|
|
|
2022 |
|
|
2021 |
|
|
% Change |
|
|
Net sales, as reported |
|
$ |
5,949.1 |
|
$ |
4,837.5 |
|
|
23.0 |
% |
|
Foreign currency translation(ii) |
|
|
— |
|
|
(12.6 |
) |
|
|
|
|
Net sales, on a constant currency basis |
|
$ |
5,949.1 |
|
$ |
4,824.9 |
|
|
23.3 |
% |
|
(i) |
There were 63 selling days for both the three months ended |
(ii) |
Represents the effect of translating the prior year results of CDW |
CDW CORPORATION AND SUBSIDIARIES |
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(dollars in millions) |
||||||||
|
||||||||
|
|
|
|
|
|
|||
Assets |
(unaudited) |
|
|
|
(unaudited) |
|||
|
|
|
|
|
|
|||
Current assets: |
|
|
|
|
|
|||
Cash and cash equivalents |
$ |
386.9 |
|
$ |
258.1 |
|
$ |
878.6 |
Accounts receivable, net of allowance for credit losses
of |
|
4,613.5 |
|
|
4,499.4 |
|
|
3,234.1 |
Merchandise inventory |
|
1,054.6 |
|
|
927.6 |
|
|
745.1 |
Miscellaneous receivables |
|
449.8 |
|
|
435.5 |
|
|
396.6 |
Prepaid expenses and other |
|
366.0 |
|
|
357.5 |
|
|
215.4 |
Total current assets |
|
6,870.8 |
|
|
6,478.1 |
|
|
5,469.8 |
|
|
|
|
|
|
|||
Operating lease right-of-use assets |
|
164.0 |
|
|
155.6 |
|
|
128.3 |
Property and equipment, net |
|
195.6 |
|
|
195.8 |
|
|
175.5 |
|
|
4,376.5 |
|
|
4,382.9 |
|
|
2,812.4 |
Other intangible assets, net |
|
1,584.6 |
|
|
1,628.1 |
|
|
419.2 |
Other assets |
|
322.3 |
|
|
358.9 |
|
|
48.3 |
Total assets |
$ |
13,513.8 |
|
$ |
13,199.4 |
|
$ |
9,053.5 |
|
|
|
|
|
|
|||
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|||
|
|
|
|
|
|
|||
Current liabilities: |
|
|
|
|
|
|||
Accounts payable - trade |
$ |
3,198.3 |
|
$ |
3,114.2 |
|
$ |
2,050.8 |
Accounts payable - inventory financing |
|
564.9 |
|
|
448.3 |
|
|
344.8 |
Current maturities of long-term debt |
|
83.9 |
|
|
102.7 |
|
|
19.6 |
Contract liabilities |
|
443.8 |
|
|
402.9 |
|
|
326.5 |
Accrued expenses and other current liabilities |
|
1,173.7 |
|
|
1,027.9 |
|
|
967.6 |
Total current liabilities |
|
5,464.6 |
|
|
5,096.0 |
|
|
3,709.3 |
|
|
|
|
|
|
|||
Long-term liabilities: |
|
|
|
|
|
|||
Debt |
|
6,514.8 |
|
|
6,755.8 |
|
|
3,911.1 |
Deferred income taxes |
|
219.3 |
|
|
222.3 |
|
|
29.2 |
Operating lease liabilities |
|
190.6 |
|
|
184.2 |
|
|
165.1 |
Other liabilities |
|
231.4 |
|
|
235.4 |
|
|
68.5 |
Total long-term liabilities |
|
7,156.1 |
|
|
7,397.7 |
|
|
4,173.9 |
|
|
|
|
|
|
|||
Total stockholders’ equity |
|
893.1 |
|
|
705.7 |
|
|
1,170.3 |
Total liabilities and stockholders’ equity |
$ |
13,513.8 |
|
$ |
13,199.4 |
|
$ |
9,053.5 |
CDW CORPORATION AND SUBSIDIARIES |
|||||||||
NET SALES DETAIL |
|||||||||
(dollars in millions) |
|||||||||
(unaudited) |
|||||||||
|
|
Three Months Ended |
|||||||
|
|
|
2022 |
|
|
2021 |
|
% Change |
|
|
|
|
|
|
|
|
|||
Corporate |
|
$ |
2,627.6 |
|
$ |
1,805.6 |
|
45.5 |
% |
|
|
|
|
|
|
|
|||
Small Business |
|
|
524.0 |
|
|
432.7 |
|
21.1 |
|
|
|
|
|
|
|
|
|||
Public |
|
|
|
|
|
|
|||
Government |
|
|
543.9 |
|
|
516.1 |
|
5.4 |
|
Education |
|
|
902.8 |
|
|
943.3 |
|
(4.3 |
) |
Healthcare |
|
|
586.3 |
|
|
462.3 |
|
26.8 |
|
Total Public |
|
|
2,033.0 |
|
|
1,921.7 |
|
5.8 |
|
|
|
|
|
|
|
|
|||
Other |
|
|
764.5 |
|
|
677.5 |
|
12.8 |
|
|
|
|
|
|
|
|
|||
Total Net sales |
|
$ |
5,949.1 |
|
$ |
4,837.5 |
|
23.0 |
% |
(i) |
There were 63 selling days for both the three months ended |
CDW CORPORATION AND SUBSIDIARIES |
|||||||||||
DEBT AND WORKING CAPITAL INFORMATION |
|||||||||||
(dollars in millions) |
|||||||||||
|
|
|
|
|
|
||||||
|
(unaudited) |
|
|
|
(unaudited) |
||||||
Debt and Revolver Availability |
|
|
|
|
|
||||||
Cash and cash equivalents |
$ |
386.9 |
|
|
$ |
258.1 |
|
|
$ |
878.6 |
|
Total debt |
|
6,598.7 |
|
|
|
6,858.5 |
|
|
|
3,930.7 |
|
Revolver availability |
|
1,042.9 |
|
|
|
987.3 |
|
|
|
1,260.0 |
|
Cash plus revolver availability |
|
1,429.8 |
|
|
|
1,245.4 |
|
|
|
2,138.6 |
|
|
|
|
|
|
|
||||||
Working Capital(i) |
|
|
|
|
|
||||||
Days of sales outstanding |
|
67 |
|
|
|
65 |
|
|
|
57 |
|
Days of supply in inventory |
|
17 |
|
|
|
17 |
|
|
|
16 |
|
Days of purchases outstanding |
|
(64 |
) |
|
|
(58 |
) |
|
|
(51 |
) |
Cash conversion cycle |
|
20 |
|
|
|
24 |
|
|
|
22 |
|
(i) |
Based on a rolling three-month average. |
CDW CORPORATION AND SUBSIDIARIES |
|||||||
CASH FLOW INFORMATION |
|||||||
(dollars in millions) |
|||||||
(unaudited) |
|||||||
|
Three Months Ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
||||
Cash flows provided by operating activities |
$ |
380.8 |
|
|
$ |
344.6 |
|
|
|
|
|
||||
Capital expenditures(i) |
|
(41.3 |
) |
|
|
(20.7 |
) |
Acquisition of business, net of cash acquired |
|
— |
|
|
|
(212.9 |
) |
Cash flows used in investing activities |
|
(41.3 |
) |
|
|
(233.6 |
) |
|
|
|
|
||||
Net change in accounts payable - inventory financing |
|
126.7 |
|
|
|
(180.3 |
) |
Financing payments for revenue generating assets |
|
— |
|
|
|
(42.9 |
) |
Other cash flows used in financing activities |
|
(334.8 |
) |
|
|
(420.3 |
) |
Cash flows used in financing activities |
|
(208.1 |
) |
|
|
(643.5 |
) |
|
|
|
|
||||
Effect of exchange rate changes on cash and cash equivalents |
|
(2.6 |
) |
|
|
0.9 |
|
Net increase (decrease) in cash and cash equivalents |
|
128.8 |
|
|
|
(531.6 |
) |
Cash and cash equivalents - beginning of period |
|
258.1 |
|
|
|
1,410.2 |
|
Cash and cash equivalents - end of period |
$ |
386.9 |
|
|
$ |
878.6 |
|
|
|
|
|
||||
Supplementary disclosure of cash flow information: |
|
|
|
||||
Interest paid |
$ |
(17.5 |
) |
|
$ |
(19.2 |
) |
Income taxes paid, net |
$ |
(11.5 |
) |
|
$ |
(10.1 |
) |
(i) |
Includes expenditures for revenue generating assets. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005140/en/
Investor Inquiries
Vice President, Investor Relations
(847) 968-0238
investorrelations@cdw.com
Media Inquiries
Vice President, Corporate Communications
(847) 419-7411
mediarelations@cdw.com
Source:
FAQ
What were CDW's earnings results for Q1 2022?
How much did CDW's net income per diluted share increase in Q1 2022?
What is CDW's growth outlook for 2022?